Home | Business News | Browse by Publication | P | Pharmaceutical Technology Europe

Tailor-made medicine drives M&As.

Publication: Pharmaceutical Technology Europe
Publication Date: 01-SEP-09
Format: Online
Delivery: Immediate Online Access

Article Excerpt
The growth of personalized medicine will bolster the number of alliances between diagnostics and pharmaceutical companies, according to a report from PricewaterhouseCoopers (PwC). As evidence of this trend, PwC cited the partnership announced in July 2009 between GlaxoSmithKline (GSK) and Enigma (UK), which was influenced by personalized medicine. "The partnership between Enigma and GSK enables significant progression towards the 'holy grail' of companion diagnostics--the ability to rapidly and...



More articles from Pharmaceutical Technology Europe
Where will the economic crisis leave pharma and biotech?, September 01, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.